152 related articles for article (PubMed ID: 23871842)
41. [Clinical study of the activity and tolerance of hydropropizine, a drug with antitussive activity].
Boselli G
Minerva Med; 1972 Jul; 63(51):2782-8. PubMed ID: 4562221
[No Abstract] [Full Text] [Related]
42. Objective assessment of cough suppressants under normal and pathological experimental conditions.
Nosál'ová G; Strapková A; Korpás J; Criscuolo D
Drugs Exp Clin Res; 1989; 15(2):77-81. PubMed ID: 2737083
[TBL] [Abstract][Full Text] [Related]
43. The 2008 Fifth International Cough Symposium: mechanisms and treatment.
Chung KF; Widdicombe J
Pulm Pharmacol Ther; 2009 Apr; 22(2):57-8. PubMed ID: 19015041
[No Abstract] [Full Text] [Related]
44. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
45. Regulating cough through modulation of sensory nerve function in the airways.
Spina D; Page CP
Pulm Pharmacol Ther; 2013 Oct; 26(5):486-90. PubMed ID: 23524012
[TBL] [Abstract][Full Text] [Related]
46. In vivo antitussive potentiality of Lagerstroemia parviflora flower extract using a cough model induced by sulfur dioxide in mice.
Mazumder A; Bhattacharya S; Mazumder R
Nat Prod Res; 2007 Mar; 21(3):217-20. PubMed ID: 17365711
[TBL] [Abstract][Full Text] [Related]
47. Current and future prospects for drugs to suppress cough.
Chung KF
IDrugs; 2003 Aug; 6(8):781-6. PubMed ID: 12917774
[TBL] [Abstract][Full Text] [Related]
48. Acute, disruptive cough. Symptomatic therapy for a nagging problem.
Zervanos NJ; Shute KM
Postgrad Med; 1994 Mar; 95(4):153-4, 157-60, 163-4 passim. PubMed ID: 8121852
[TBL] [Abstract][Full Text] [Related]
49. Chronic cough: an approach to management.
Corrao WM
Compr Ther; 1986 Jul; 12(7):14-9. PubMed ID: 2873919
[TBL] [Abstract][Full Text] [Related]
50. Brain activity associated with placebo suppression of the urge-to-cough in humans.
Leech J; Mazzone SB; Farrell MJ
Am J Respir Crit Care Med; 2013 Nov; 188(9):1069-75. PubMed ID: 24093551
[TBL] [Abstract][Full Text] [Related]
51. [Effects of antitussive drugs in the central part of the cough reflex tract].
Hahn KJ; Friebel H
Med Pharmacol Exp Int J Exp Med; 1966; 14(1):87-97. PubMed ID: 5952131
[No Abstract] [Full Text] [Related]
52. Adverse events from cough and cold medications after a market withdrawal of products labeled for infants.
Shehab N; Schaefer MK; Kegler SR; Budnitz DS
Pediatrics; 2010 Dec; 126(6):1100-7. PubMed ID: 21098150
[TBL] [Abstract][Full Text] [Related]
53. [Sputum viscosimetric studies of an antitussive dihydrobenzoxazine derivative].
Stresemann E; Gürbüz L; Oswald WD
Arzneimittelforschung; 1974 Dec; 24(12):2053-5. PubMed ID: 4480284
[No Abstract] [Full Text] [Related]
54. [Considerations on antitussive treatments in pediatrics: The use of a new compound: medazonamide].
Berio A
Clin Ter; 1967 Jan; 40(1):27-35. PubMed ID: 5604245
[No Abstract] [Full Text] [Related]
55. Cough: physiology, evaluation, and treatment.
Banner AS
Lung; 1986; 164(2):79-92. PubMed ID: 3084882
[No Abstract] [Full Text] [Related]
56. [Prolonged cough in adults].
Tukiainen P
Duodecim; 1998; 114(21):2193-8. PubMed ID: 11757108
[No Abstract] [Full Text] [Related]
57. Central nervous mechanisms in cough.
Jordan D
Pulm Pharmacol; 1996; 9(5-6):389-92. PubMed ID: 9232683
[No Abstract] [Full Text] [Related]
58. Antitussive effect of naringin on experimentally induced cough in Guinea pigs.
Gao S; Li P; Yang H; Fang S; Su W
Planta Med; 2011 Jan; 77(1):16-21. PubMed ID: 20645246
[TBL] [Abstract][Full Text] [Related]
59. [Experiences on the subject of the objective evaluation of antitussive drugs in man].
Frigerio G; Lodola E; Porsio A; Borgia M; Gambini A
Boll Chim Farm; 1966 Feb; 105(2):154-60. PubMed ID: 5328079
[No Abstract] [Full Text] [Related]
60. Evidence for a central site of action for the antitussive effects of caramiphen.
Domino EF; Krutak-Krol H; Lal J
J Pharmacol Exp Ther; 1985 Apr; 233(1):249-53. PubMed ID: 3981459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
